Clinical trial
Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)
NCT02808871
Study timeline
Study start (actual)2017-04-07Date precision: day
Registry last updated2022-08-16
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Interventions
PirfenidoneDRUG · verified · RxNorm: pirfenidone
PlaceboDRUG
Sponsors & collaborators
Brigham and Women's Hospitallead sponsor
Mapped research locations
New YorkNew York, United States1BostonMassachusetts, United States1BaltimoreMaryland, United States1MiamiFlorida, United States1TorontoOntario, Canada1NashvilleTennessee, United States1San FranciscoCalifornia, United States1LondonUnited Kingdom1SeattleWashington, United States1BirminghamAlabama, United States1DenverColorado, United States1Ann ArborMichigan, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02808871 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.